Phenotypes and Therapy Strategies in Exercise-induced Bronchoconstriction

In the field of sports medicine, exercise-induced bronchoconstriction (EIB) presents a significant challenge due to its transient narrowing of airways post-exertion, which results in symptoms like wheezing, coughs, and breathlessness. Primarily affecting individuals with or without asthma, the condition is notably prevalent among athletes,
reaching up to 90% in those with asthma and substantially present in elite athletes engaging in cold environment sports. Traditional studies have documented the varied prevalence and emphasized associations with environmental conditions and sporting types, highlighting the heterogeneous nature of EIB across different groups.

This Research Topic aims to explore the complexities of diagnosing and managing EIB specifically within athlete populations, recognizing the critical need to distinguish between symptomatic displays and actual bronchoconstrictive responses. The goals include an enhanced understanding of the underlying physiological mechanisms, development of more accurate diagnostic tools that consider the unique requirements of athletes, and exploration of treatment regimens that comply with anti-doping laws while effectively mitigating the symptoms and potential performance debilitation
associated with EIB.

To gather further insights into the nuances of athlete-specific EIB, we welcome articles addressing, but not limited to, the following themes:
• Physiological mechanisms underlying EIB
• Innovations in diagnostic methodologies tailored for athletes
• Impact of environmental conditions on EIB prevalence among different sports
• Comparative analysis of symptomatic treatment effectiveness and side effects
• Long-term health outcomes of athletes managing EIB